These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 16786124

  • 1. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, Slomski R.
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [Abstract] [Full Text] [Related]

  • 2. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P, Liu J, Zeng X, Li W, Tang J.
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [Abstract] [Full Text] [Related]

  • 3. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL, Cai L, Xiang ZL, Zhuo WL, Wang Y, Zhang XY.
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [Abstract] [Full Text] [Related]

  • 4. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP, Frazzon AP, Damin DC, Roehe A, Hermes V, Zettler C, Alexandre CO.
    Cancer Detect Prev; 2006 May; 30(6):523-9. PubMed ID: 17113725
    [Abstract] [Full Text] [Related]

  • 5. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M, Morán Y, Camargo ME, Rivero MB, Bohórquez A, Villegas V, Ramírez E, Rendón Y, Suárez A, Morales L, Useche E, Salazar S, Zambrano A, Ramírez A, Valderrama E, Briceño Z, Chiurillo MA.
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [Abstract] [Full Text] [Related]

  • 6. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL, Li Q, Zhou Y, Cai L, Xiang ZL, Yuan W, Zhang XY.
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [Abstract] [Full Text] [Related]

  • 7. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
    Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A.
    Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
    [Abstract] [Full Text] [Related]

  • 8. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [Abstract] [Full Text] [Related]

  • 9. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, Dienemann H, Risch A, Bartsch H, Schmezer P.
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [Abstract] [Full Text] [Related]

  • 10. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F, Morari J, Morari EC, Correa LA, Assumpção LV, Ward LS.
    Cancer Lett; 2004 Jul 16; 210(2):151-7. PubMed ID: 15183530
    [Abstract] [Full Text] [Related]

  • 11. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
    Santos AM, Sousa H, Catarino R, Pinto D, Pereira D, Vasconcelos A, Matos A, Lopes C, Medeiros R.
    Cancer Genet Cytogenet; 2005 Jun 16; 159(2):143-7. PubMed ID: 15899386
    [Abstract] [Full Text] [Related]

  • 12. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B, Toumi N, Khabir A, Sellami-Boudawara T, Ghorbel A, Daoud J, Frikha M, Gargouri A, Mokdad-Gargouri R.
    Cancer Genet Cytogenet; 2007 Oct 15; 178(2):89-93. PubMed ID: 17954263
    [Abstract] [Full Text] [Related]

  • 13. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
    Boltze C, Roessner A, Landt O, Szibor R, Peters B, Schneider-Stock R.
    Int J Oncol; 2002 Nov 15; 21(5):1151-4. PubMed ID: 12370767
    [Abstract] [Full Text] [Related]

  • 14. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y, McDermott MP, Ahrendt SA.
    Clin Cancer Res; 2005 Apr 01; 11(7):2502-9. PubMed ID: 15814626
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
    Ghasemi N, Karimi-Zarchi M, Mortazavi-Zadeh MR, Atash-Afza A.
    Cancer Genet Cytogenet; 2010 Jan 15; 196(2):167-70. PubMed ID: 20082853
    [Abstract] [Full Text] [Related]

  • 16. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
    Bau DT, Tsai MH, Lo YL, Hsu CM, Tsai Y, Lee CC, Tsai FJ.
    Anticancer Res; 2007 Jan 15; 27(3B):1559-64. PubMed ID: 17595776
    [Abstract] [Full Text] [Related]

  • 17. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
    Drummond SN, De Marco L, Pordeus Ide A, Barbosa AA, Gomez RS.
    Anticancer Res; 2002 Jan 15; 22(6A):3379-81. PubMed ID: 12530090
    [Abstract] [Full Text] [Related]

  • 18. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-Prado JC, Reis PM, de Freitas SE, Filho JF, Fukuyama EE, Cordeiro JA, Cury PM, Maniglia JV, Villa LL, Tajara EH, Rahal P.
    Cancer Genet Cytogenet; 2004 Apr 01; 150(1):44-9. PubMed ID: 15041222
    [Abstract] [Full Text] [Related]

  • 19. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P, Sengupta S.
    Gynecol Oncol; 2005 Oct 01; 99(1):176-82. PubMed ID: 16054204
    [Abstract] [Full Text] [Related]

  • 20. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
    Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Crinière E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY.
    Cancer Genet Cytogenet; 2007 Sep 01; 177(2):103-7. PubMed ID: 17854663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.